Trials / Completed
CompletedNCT04641130
Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC
Validation and Reproducibility Study of the ALYATEC Allergen Exposure Chamber by Determining the Concentration of Birch Pollen Allergen Inducing Conjunctivitis in Subjects Allergic to Birch Pollen.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Alyatec · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a single center open study designed to determine the concentration of airborne birch pollen inducing an allergic conjunctivitis response in individuals allergic to birch pollen, during allergen exposures in the Alyatec environmental exposure chamber (EEC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exposure to birch pollen in EEC | Patients are exposed to airborne birch pollen allergen. The duration of each exposure is 4h maximum. |
Timeline
- Start date
- 2017-07-13
- Primary completion
- 2017-08-30
- Completion
- 2017-09-11
- First posted
- 2020-11-23
- Last updated
- 2020-12-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04641130. Inclusion in this directory is not an endorsement.